HP
OXFD

Hound Partners’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Hound Partners’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-32,302
Closed -$524K – 40
2018
Q3 		$524K Buy
+32,302
New +$462K 0.01% 29

Other funds holding OXFD

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

Hound Partners's OXFD Position: Q4 2018 in Review

Hound Partners sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q4 2018, closing a stake of 32,302 shares — an estimated $524K sold.

Hound Partners first reported a position in OXFD in Q3 2018 and held it in 1 quarter. The position peaked at $524K in Q3 2018. 82 funds tracked by Wall St. Rank hold OXFD as of Q4 2018.

  • Hound Partners reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q4 2018 after selling out during the quarter.
  • Hound Partners sold 32,302 Oxford Immunotec Global PLC Ordinary Shares shares in Q4 2018, an estimated $524K.
  • Hound Partners first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q3 2018 and held it in 1 quarter.
  • Hound Partners's Oxford Immunotec Global PLC Ordinary Shares position peaked at $524K in Q3 2018.
  • 82 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q4 2018.

Based on Hound Partners's 13F filing for Q4 2018, filed 14 Feb 2019.